Fernandez Salamanca M, van Houdt PJ, Hompland T, Deręgowska-Cylke M, van Leeuwen PJ, van der Poel HG, Bekers E, Guimaraes MAS, Lyng H, van der Heide UA, Schoots IG(2025) Hypoxia and cribriform growth in prostate cancer - establishing a link via MRI BMC Med Imaging(in press) DOI 10.1186/s12880-025-02084-3, PubMed 41366753
Stenberg VY, Liukaityte R, Kristiansen SK, Wangen-Riise R, Kleinauskas A, Dunne V, Juzeniene A(2025) Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001 Sci Rep(in press) DOI 10.1038/s41598-025-29785-7, PubMed 41318731
Arous D, Larsen Lie J, Jeppesen Edin NF, Malinen E(2025) Integrating 2D dosimetry and cell survival analysis for predicting local effect in spatially fractionated radiotherapy Acta Oncol, 64, 1465-1472 DOI 10.2340/1651-226X.2025.44599, PubMed 41132002
